TSLA Tesla, Inc.
Motor Vehicles & Passenger Car Bodies · Nasdaq · SEC CIK 1318605 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY8.3%
TTM net income YoY-38.9%
TTM EPS YoY-37.2%
Revenue 3-yr CAGR2.6%
Net income 3-yr CAGR-33.1%
Margins
Gross margin19.3%
Operating margin3.3%
Net margin3.1%
FCF margin3.2%
EBITDA margin8.8%
Returns
ROE3.8%
ROA2.2%
ROIC (approx.)3.6%
Asset turnover0.71x
Leverage & solvency
Liabilities / assets42.9%
Debt / equity0.10x
Current ratio1.74x
Interest coverage9.96x
Cash quality & payout
Operating cash flow / net income5.81x
Accruals ratio-10.6%
Payout ratio—
Capex / revenue14.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $94.83B | $97.69B |
| Cost of revenue | $77.73B | $80.24B |
| Gross profit | $17.09B | $17.45B |
| R&D expense | $6.41B | $4.54B |
| SG&A expense | $5.83B | $5.15B |
| Operating income | $4.36B | $7.08B |
| Interest expense | $338.00M | $350.00M |
| Pretax income | $5.28B | $8.99B |
| Income tax | $1.42B | $1.84B |
| Net income | $3.79B | $7.09B |
| EBITDA | $9.38B | $11.20B |
| EPS (basic) | 1.18 | 2.23 |
| EPS (diluted) | 1.08 | 2.04 |
| Weighted avg. shares (diluted) | 3.53B | 3.50B |
| Balance sheet | ||
| Cash & equivalents | $16.51B | $16.14B |
| Short-term investments | $27.55B | $20.42B |
| Receivables | $4.58B | $4.42B |
| Inventory | $12.39B | $12.02B |
| Current assets | $68.64B | $58.36B |
| PP&E, net | $40.64B | $35.84B |
| Goodwill | $257.00M | $244.00M |
| Intangibles | $124.00M | $150.00M |
| Total assets | $137.81B | $122.07B |
| Current liabilities | $31.71B | $28.82B |
| Short-term debt | $1.57B | $2.34B |
| Long-term debt | $6.58B | $5.54B |
| Total debt | $8.15B | $7.88B |
| Total liabilities | $54.94B | $48.39B |
| Shareholders' equity | $82.14B | $72.91B |
| Net debt | -$8.36B | -$8.26B |
| Shares outstanding | 3.75B | 3.22B |
| Cash flow statement | ||
| Operating cash flow | $14.75B | $14.92B |
| Capital expenditure | $8.53B | $11.34B |
| Free cash flow | $6.22B | $3.58B |
| Investing cash flow | -$15.48B | -$18.79B |
| Financing cash flow | $1.14B | $3.85B |
| Depreciation & amortization | $5.03B | $4.12B |
| Stock-based compensation | $2.83B | $2.00B |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.